Decursin and Decursinol from Angelica gigas Inhibit the Lung Metastasis of Murine Colon Carcinoma
Authors:
- 16 December 2010
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 25 (7) , 959-964
Abstract
The principal objective of the present study was to evaluate the antimetastatic activity of decursin and decursinol isolated from Angelica gigas. Decursin and decursinol inhibited the proliferation and invasion of CT‐26 colon carcinoma cells. The expressions of matrix metalloproteinase (MMP)‐2 and MMP‐9 in cells and the activities in the culture medium were also reduced by decursin and decursinol treatment. In CT‐26 cells, the extracellular signal‐regulated kinase (ERK) inhibitor inhibited cell proliferation, invasion and MMP‐9 expression, and the c‐Jun N‐terminal kinase (JNK) inhibitor suppressed the expression of both MMPs, as well as cell proliferation and cell invasion. The phosphatidylinositol‐3 kinase (PI3K) inhibitor reduced only the expression of MMP‐2. In addition, the invasion of CT‐26 cells was inhibited by the treatment with anti‐MMP‐9 antibody, rather than anti‐MMP‐2 antibody. These results indicate that MMP‐9 expression via ERK and JNK plays a critical role for the invasion of CT26 cells. Decursin and decursinol downregulated ERK and JNK phosphorylation. Moreover, oral administration of decursin and decursinol reduced the formation of tumor nodules in the lungs and the increase in lung weight caused by CT‐26 metastases. Therefore, both decursin and decursinol may be benefi cial antimetastatic agents, targeting MMPs and their upstream signaling molecules. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 25 references indexed in Scilit:
- Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studiesBritish Journal of Nutrition, 2010
- Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinaseCancer Letters, 2009
- Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathwayCarcinogenesis, 2009
- Decursin Suppresses Human Androgen-Independent PC3 Prostate Cancer Cell Proliferation by Promoting the Degradation of β-CateninMolecular Pharmacology, 2007
- Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cellsBreast Cancer Research, 2007
- Cyclooxygenase-2 inhibition in colorectal cancer: Boom or bust?Seminars in Oncology, 2005
- The role of gelatinases in colorectal cancer progression and metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Treatment of epigallocatechin‐3‐gallate inhibits matrix metalloproteinases‐2 and ‐9 via inhibition of activation of mitogen‐activated protein kinases, c‐jun and NF‐κB in human prostate carcinoma DU‐145 cellsThe Prostate, 2003
- Activity and cellular origin of gelatinases in patients with colon and rectal carcinomaCancer, 2001
- Decursin: A Cytotoxic Agent and Protein Kinase C Activator from the Root ofAngelica gigasPlanta Medica, 1996